Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11948169Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$3.2M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#2,985
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Tuomas Tammela as a PI. Multi-PI records show the full award amount for context.
- 1R01CA297077-01R01Metabolic control of malignant fates in lung cancer$730.4Kaward amount
- 5R01CA293718-02R01Targeting cell state transitions driving resistance to KRAS inhibitors in lung cancer$718.3Kaward amount
- 5R01CA290400-02R01Investigating hypoxia as a determinant of malignant fates in pancreas cancer$695.1Kaward amount
- $611.3Kaward amount
- 4R37CA244911-06R37Targeting stem-like cells and their niche in pancreatic cancer$490.8Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Tuomas Tammela as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMemorial Sloan Kettering Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3649
- 2024Entered Top 25% NationallyRanked #3649
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026Entered Top 10% NationallyRanked #1281
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Tuomas Tammela.